Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
41M
-
Number of holders
-
53
-
Total 13F shares, excl. options
-
21.9M
-
Shares change
-
+21.8M
-
Total reported value, excl. options
-
$389M
-
Value change
-
+$388M
-
Number of buys
-
50
-
Price
-
$17.86
Significant Holders of ArriVent BioPharma, Inc. - Common Stock (AVBP) as of Q1 2024
53 filings reported holding AVBP - ArriVent BioPharma, Inc. - Common Stock as of Q1 2024.
ArriVent BioPharma, Inc. - Common Stock (AVBP) has 53 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.9M shares
of 41M outstanding shares and own 53.34% of the company stock.
Largest 10 shareholders include HHLR ADVISORS, LTD. (3.93M shares), ORBIMED ADVISORS LLC (3.03M shares), FMR LLC (1.95M shares), Octagon Capital Advisors LP (1.94M shares), Sofinnova Investments, Inc. (1.7M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (1.56M shares), General Catalyst Group Management, LLC (1.49M shares), Novo Holdings A/S (1.08M shares), HSG Holding Ltd (663K shares), and BlackRock Inc. (655K shares).
This table shows the top 53 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.